SHELL ASSET MANAGEMENT CO - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 159 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$100
-35.9%
23,262
-1.5%
0.00%
-33.3%
Q2 2023$156
-24.6%
23,625
-22.6%
0.01%
-33.3%
Q1 2023$207
-8.4%
30,524
-0.4%
0.01%
-10.0%
Q4 2022$226
-99.9%
30,632
-17.3%
0.01%
-28.6%
Q3 2022$366,000
-28.2%
37,055
-20.8%
0.01%
-6.7%
Q2 2022$510,000
-3.4%
46,767
+0.2%
0.02%
+25.0%
Q1 2022$528,000
-37.2%
46,688
-12.9%
0.01%
-29.4%
Q4 2021$841,000
-8.0%
53,597
+0.5%
0.02%
-19.0%
Q3 2021$914,000
-23.6%
53,353
-4.1%
0.02%
-8.7%
Q2 2021$1,197,000
+81.6%
55,653
+26.8%
0.02%
+76.9%
Q1 2021$659,000
+57.7%
43,900
+37.9%
0.01%
+44.4%
Q4 2020$418,000
+330.9%
31,832
+218.6%
0.01%
+350.0%
Q3 2020$97,000
-14.9%
9,9920.0%0.00%
-33.3%
Q2 2020$114,000
-78.9%
9,992
-66.9%
0.00%
-75.0%
Q3 2017$540,000
+7.4%
30,168
-2.3%
0.01%
+9.1%
Q2 2017$503,000
+16.4%
30,8680.0%0.01%
+22.2%
Q1 2017$432,000
-18.0%
30,868
-6.5%
0.01%
-25.0%
Q4 2016$527,00033,0280.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders